23 Oct 2026
byDr. Eiichi Ogawa, Specialist in Hepatology, Kyushu University Hospital, Fukuoka, Japan
A 60-year-old male presented with abnormal liver function test results following a routine health evaluation in 2014. He was asymptomatic, with baseline Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0. Comorbidities included hypertension and dyslipidaemia, managed with amlodipine and a statin, respectively.
